Laura E. Warner

1.7k total citations
19 papers, 1.3k citations indexed

About

Laura E. Warner is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cell Biology. According to data from OpenAlex, Laura E. Warner has authored 19 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cellular and Molecular Neuroscience, 10 papers in Molecular Biology and 7 papers in Cell Biology. Recurrent topics in Laura E. Warner's work include Hereditary Neurological Disorders (17 papers), RNA regulation and disease (5 papers) and RNA Research and Splicing (5 papers). Laura E. Warner is often cited by papers focused on Hereditary Neurological Disorders (17 papers), RNA regulation and disease (5 papers) and RNA Research and Splicing (5 papers). Laura E. Warner collaborates with scholars based in United States, Belgium and Israel. Laura E. Warner's co-authors include James R. Lupski, Pedro Mancías, Craig M. McDonald, Ian J. Butler, Laura Davis Keppen, Christine Van Broeckhoven, Eva Nelis, Carlos García, David R. Witt and Max J. Hilz and has published in prestigious journals such as Neuron, Nature Genetics and Neurology.

In The Last Decade

Laura E. Warner

19 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura E. Warner United States 13 1.1k 488 364 332 243 19 1.3k
Els De Vriendt Belgium 21 1.1k 1.0× 769 1.6× 440 1.2× 363 1.1× 549 2.3× 40 1.8k
Nathalie Verpoorten Belgium 8 526 0.5× 391 0.8× 231 0.6× 254 0.8× 327 1.3× 9 1.0k
Gerard W. Hensels Netherlands 12 663 0.6× 349 0.7× 273 0.8× 253 0.8× 167 0.7× 12 923
Jamïlé Hazan France 21 1.3k 1.2× 532 1.1× 745 2.0× 386 1.2× 504 2.1× 38 1.9k
Katrin Adlkofer Switzerland 8 769 0.7× 308 0.6× 283 0.8× 245 0.7× 198 0.8× 9 967
JoAnn Bergoffen United States 11 577 0.5× 634 1.3× 148 0.4× 294 0.9× 95 0.4× 13 1.2k
Irene Sargiannidou Cyprus 23 637 0.6× 696 1.4× 244 0.7× 267 0.8× 112 0.5× 48 1.3k
Vito Guzzetta Italy 6 810 0.8× 361 0.7× 263 0.7× 324 1.0× 135 0.6× 7 1.2k
Federica Taioli Italy 16 547 0.5× 220 0.5× 189 0.5× 303 0.9× 157 0.6× 43 749
C. Stewart Gillespie United Kingdom 12 694 0.7× 489 1.0× 177 0.5× 143 0.4× 256 1.1× 17 1.0k

Countries citing papers authored by Laura E. Warner

Since Specialization
Citations

This map shows the geographic impact of Laura E. Warner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura E. Warner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura E. Warner more than expected).

Fields of papers citing papers by Laura E. Warner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura E. Warner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura E. Warner. The network helps show where Laura E. Warner may publish in the future.

Co-authorship network of co-authors of Laura E. Warner

This figure shows the co-authorship network connecting the top 25 collaborators of Laura E. Warner. A scholar is included among the top collaborators of Laura E. Warner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura E. Warner. Laura E. Warner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Warner, Laura E.. (2002). Expression of Dp260 in muscle tethers the actin cytoskeleton to the dystrophin-glycoprotein complex and partially prevents dystrophy. Human Molecular Genetics. 11(9). 1095–1105. 64 indexed citations
2.
Gutierrez, Amparo, John D. England, Austin J. Sumner, et al.. (2000). Unusual electrophysiological findings in X-linked dominant Charcot-Marie-Tooth disease. Muscle & Nerve. 23(2). 182–188. 68 indexed citations
3.
Warner, Laura E.. (1999). Functional consequences of mutations in the early growth response 2 gene (EGR2) correlate with severity of human myelinopathies. Human Molecular Genetics. 8(7). 1245–1251. 102 indexed citations
4.
Boerkoel, Cornelius F., Ken Inoue, Lawrence T. Reiter, Laura E. Warner, & James R. Lupski. (1999). Molecular Mechanisms for CMT1A Duplication and HNPP Deletion. Annals of the New York Academy of Sciences. 883(1). 22–35. 34 indexed citations
5.
Phillips, J. P., Laura E. Warner, James R. Lupski, & Bhuwan P. Garg. (1999). Congenital hypomyelinating neuropathy: two patients with long-term follow-up. Pediatric Neurology. 20(3). 226–232. 33 indexed citations
6.
Timmerman, Vincent, Peter De Jonghe, C. Ceuterick, et al.. (1999). Novel missense mutation in the early growth response 2 gene associated with Dejerine–Sottas syndrome phenotype. Neurology. 52(9). 1827–1827. 121 indexed citations
7.
Warner, Laura E., Carlos García, & James R. Lupski. (1999). Hereditary Peripheral Neuropathies: Clinical Forms, Genetics, and Molecular Mechanisms. Annual Review of Medicine. 50(1). 263–275. 65 indexed citations
8.
Warner, Laura E., Pedro Mancías, Ian J. Butler, et al.. (1998). Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nature Genetics. 18(4). 382–384. 373 indexed citations
9.
Warner, Laura E., Mordechai Shohat, Zamir Shorer, & James R. Lupski. (1997). Multiplede novo MPZ (P0) point mutations in a sporadic Dejerine-Sottas case. Human Mutation. 10(1). 21–24. 21 indexed citations
10.
Warner, Laura E., Mordechai Shohat, Zamir Shorer, & James R. Lupski. (1997). Multiple de novo MPZ (P0) point mutations in a sporadic Dejerine‐Sottas case. Human Mutation. 10(1). 21–24. 1 indexed citations
11.
Warner, Laura E., Benjamin B. Roa, & James R. Lupski. (1996). Absence ofPMP22 coding region mutations in CMT1A duplication patients: Further evidence supporting gene dosage as a mechanism for charcot-marie-tooth disease type 1A. Human Mutation. 8(4). 362–365. 28 indexed citations
12.
Roa, Benjamin B., Laura E. Warner, Carlos A. Garcia, et al.. (1996). Myelin protein zero (MPZ) gene mutations in nonduplication type 1 Charcot-Marie-Tooth disease. Human Mutation. 7(1). 36–45. 57 indexed citations
13.
Warner, Laura E., Max J. Hilz, Stanley H. Appel, et al.. (1996). Clinical Phenotypes of Different MPZ (P0) Mutations May Include Charcot–Marie–Tooth Type 1B, Dejerine–Sottas, and Congenital Hypomyelination. Neuron. 17(3). 451–460. 288 indexed citations
14.
15.
Reiter, Lawrence T., T. Murakami, Laura E. Warner, & James R. Lupski. (1996). DNA rearrangements affecting dosage sensitive genes. Mental Retardation and Developmental Disabilities Research Reviews. 2(3). 139–146. 4 indexed citations
16.
Warner, Laura E., Lawrence T. Reiter, T. Murakami, & James R. Lupski. (1996). . Cold Spring Harbor Symposia on Quantitative Biology. 61(1). 659–671. 6 indexed citations
17.
Warner, Laura E., Benjamin B. Roa, & James R. Lupski. (1996). Absence of PMP22 coding region mutations in CMT1A duplication patients: Further evidence supporting gene dosage as a mechanism for charcot‐marie‐tooth disease type 1A. Human Mutation. 8(4). 362–365. 4 indexed citations
18.
Roa, Benjamin B., Laura E. Warner, Carlos García, et al.. (1996). Myelin protein zero (MPZ) gene mutations in nonduplication type 1 Charcot‐Marie‐Tooth disease. Human Mutation. 7(1). 36–45. 3 indexed citations
19.
Roa, B. B., Laura E. Warner, & J.R. Lupski. (1994). Mutational analysis of the myelin protein zero (MPZ) gene associated with Charcot-Marie-Tooth neuropathy type 1B. The American Journal of Human Genetics. 55. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Els De Vriendt Breakdown of academic impact, for papers by Nathalie Verpoorten Breakdown of academic impact, for papers by Gerard W. Hensels Breakdown of academic impact, for papers by Jamïlé Hazan Breakdown of academic impact, for papers by Katrin Adlkofer Breakdown of academic impact, for papers by JoAnn Bergoffen Breakdown of academic impact, for papers by Irene Sargiannidou Breakdown of academic impact, for papers by Vito Guzzetta Breakdown of academic impact, for papers by Federica Taioli Breakdown of academic impact, for papers by C. Stewart Gillespie
Rankless by CCL
2026